Food Manufacturer General Mills (NYSE:GIS) is looking for innovative ingredients or technologies to "go beyond the known impact of calcium and vitamin D" to increase bone formation process through cultured foods.The food giant, who has a sturdy presence in the world’s yogurt market through its Yoplait brand, is finding new ways to boost calcium absorption, either by adding new ingredients, finding new foundations of calcium or fresh processing techniques.General Mills has a potential upside of 11% based on a current price of $36.81 and an average consensus analyst price target of $40.87.